MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism

Simple item page
dc.contributor.authorKongrat S.
dc.contributor.authorSungkaworn T.
dc.contributor.authorMuanprasat C.
dc.contributor.authorSriphrapradang C.
dc.contributor.authorYingchoncharoen T.
dc.contributor.correspondenceKongrat S.
dc.contributor.otherMahidol University
dc.date.accessioned2024-10-05T18:40:15Z
dc.date.available2024-10-05T18:40:15Z
dc.date.issued2024-09-01
dc.identifier.citationDiabetes & vascular disease research Vol.21 No.5 (2024)
dc.identifier.doi10.1177/14791641241278527
dc.identifier.eissn17528984
dc.identifier.pmid39325062
dc.identifier.scopus2-s2.0-85204941101
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/101503
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleMicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85204941101&origin=inward
oaire.citation.issue5
oaire.citation.titleDiabetes & vascular disease research
oaire.citation.volume21
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University

Files

Collections

Scopus 2024